← Back to all trials
Completed
NCT02065310
N2-(1-carboxyethyl)-2'Deoxyguanosine (CEdG) a Potential Biomarker for Diabetes
Conditions: Diabetes
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: NA
Enrollment: 26
Sponsor: City of Hope Medical Center
Location: City of Hope Medical Center Duarte California
Summary
The purpose of this study is to see if the CEdG assay can produce internally consistent results and initiate its validation as a biomarker for diabetes in humans.
Eligibility Criteria
Inclusion Criteria:
* 18 years of age or older
* Registered patient of City of Hope
* Documentation of a diagnosis of diabetes identified by the problem list in the patient's electronic health record
Exclusion Criteria:
* Current pregnancy
* An active diagnosis of cancer, as CEdG levels may potentially be affected by malignant processes
Source: ClinicalTrials.gov (NCT02065310). StuddyBuddy aggregates publicly available trial information.
